Nationally Recognized Bladder Cancer Surgeon Dr. Robert Svatek Visits DHR Health

Translate to Spanish or other 102 languages!

DHR Health Urology Insitute physicians with Dr. Svatek during visit.  Left to Right: Dr. Henry Ruiz, Medical Director at DHR Health Urology Insitute, Dr. Robert Svatek, Chair of Urology at UTHSCSA, Dr. Gustavo Villegas, Dr. Maria Rodriguez, and Dr. Gaudencio Olguin.

Mega Doctor News

- Advertisement -

Edinburg, TX – Dr. Robert Svatek, the Chair of Urology at UT Science Center at San Antonio (UTHSCSA) and one of the top five highest volume bladder cancer surgeons in the United States, visited DHR Health and DHR Health Institute for Research and Development to discuss collaborative efforts that will continue to enhance the ongoing partnership of advancing clinical care and research benefiting Rio Grande Valley residents.

“Dr. Robert Svatek is a nationally recognized urologic surgeon-scientist with clinical expertise in early and late phase clinical trials and urologic cancers” said Dr. Henry Ruiz, Medical Director at DHR Health Urology Institute. “Many areas of common clinical and research interests were discussed and we look forward to continuing to work with Dr. Svatek and his team at UTHSCSA to provide the highest level of care to members of our community”.

DHR Health has endowed a Distinguished Chair in Urology at UTHSCSA. The primary objective of this endowment is to create a closer and more productive partnership between the institutions, which would benefit the Rio Grande Valley community. American Cancer Society has projected that over 248,000 patients will be diagnosed with prostate cancer in 2021 and more than 34,000 will have a fatal outcome. In addition, according to the Prostate Cancer Foundation, prostate cancer is the most commonly diagnosed cancer among Hispanic/Latino men in the United States.  

- Advertisement -

“Bladder cancer is also a serious clinical challenge in the Rio Grande Valley” said Dr. Sohail Rao, president and chief executive officer at DHR Health Institute for Research and Development.   “American Cancer Society has predicted that more than 83,700 patients will be diagnosed with bladder cancer in 2021 with a very high incidence (>20%) of fatal outcome.  Given Dr. Svatek’s interest in developing innovative strategies to treat bladder cancer, our goal is to work closely with his team at UTHSCSA to partner in these innovative clinical studies”.

For more information on research studies and collaborations, please contact Dr. Sohail Rao, president and chief executive officer at DHR Health Institute for Research and Development at (956) 362-2387 or visit www.dhrresearch.org.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Stands Alone as Only “Breast Center of Excellence” in Deep South Texas

During the month of October, DHR Health would like to remind the community that it is home to only "Breast Center of Excellence," accredited by the National Accreditation Program for Breast Centers (NAPBC). This is a designation DHR Health has had since 2015 and is the only Breast Center of Excellence found south of San Antonio, Corpus Christi, and Laredo. 

Op Ed: Turn awareness into action: Why breast cancer screening matters

Mega Doctor News By Lorena Saenz Gonzalez Breast cancer affects the lives of millions of women and...

RGV Cartilage Restoration Expert Dr. Daniel Romanelli Celebrates 100th MACI Procedure

DHR Health is pleased to announce that Orthopedic Sports Surgeon Dr. Daniel Romanelli has achieved his 100th MACI procedure. He was the first orthopedic surgeon to perform the MACI procedure in the Rio Grande Valley, an advanced cartilage restoration procedure for treating certain knee cartilage injuries.

STHS Clinics Surgeon Dr. Miguel Rodriguez Earns Prestigious National Recognition

Miguel Rodriguez, DO, FACS, a general, robotic and bariatric surgeon with STHS Clinics, has been inducted as a Fellow of the American College of Surgeons (ACS), earning the prestigious FACS designation.
- Advertisement -